Navigation Links
MedImmune Licenses Reverse Genetics Technology to Hungary's Omninvest for Use in Influenza Vaccine Development and Production
Date:10/16/2008

Second Agreement Signed in Third Quarter of 2008 Expands Worldwide

Application of Cutting-Edge Influenza Vaccine Technology

GAITHERSBURG, Md., Oct. 16 /PRNewswire/ -- MedImmune announced today that it has licensed its proprietary reverse genetics intellectual property to Omninvest, a Hungarian research and manufacturing company, to support the development and construction of new vaccine strains to produce non-live human influenza vaccines. Reverse genetics is a method by which viruses such as influenza can be generated from segments of DNA. For potential pandemic influenza vaccines, reverse genetics can be a useful technology because the process does not require manufacturers to work directly with potentially highly infectious pandemic strains, such as H5N1, rather only with segments of the virus's genome. This announcement marks the second agreement of this kind that MedImmune signed in the third quarter of 2008.

"Omninvest has demonstrated decades of commitment to providing protection against influenza, and we commend their commitment to donate some of their product to the World Health Organization (WHO) stockpile for distribution among developing nations," said MedImmune's Jonathan Klein-Evans, vice president, intellectual property. "MedImmune is pleased to license our reverse genetics technology to Omninvest as we have done previously to five other influenza vaccine manufacturers."

MedImmune will receive an upfront payment and has the potential to receive royalties on certain vaccine stockpiles or sales of other influenza products developed using the reverse genetics technology.

Most influenza vaccine manufacturing companies and governmental agencies are now using reverse genetics technology in their development of pandemic vaccine candidates because it allows them to avoid working directly with the infectious, circulating pandemic strains. As the owner or exclusive licensee of key patent estates for use of the rev
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
2. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
3. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
4. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
5. Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
6. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
7. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
8. Seneca Valley High School Student Receives Science Award From MedImmune
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. MedImmune Submits Biologics License Application to FDA for Motavizumab
11. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a lead...today that it executed,a joint venture (JV) agreem...gy Co., Ltd. (Sinovac Dalian). The JV will researc...ccines. Sinovac will contribute its expertise,and ...-class vaccines; the,other party will bring its la...
(Date:11/25/2009)...rstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA...president and chief executive officer, will presen...ference. , ,Presentation details are as follows:,...Date: Tuesday, December 1, 2009,Time: 2:...e Hotel, New York, NY,Webcast: <a href=,http://...
(Date:11/24/2009)...irstCall/ -- IES (Nasdaq: IESC ), a leading natio...ems and services for the commercial, industrial an...mmercial business group has been awarded a contrac...al systems for the Level 4 bio-safety lab (BSL-4) ...arch Institute of Infectious Diseases (USAMRIID) a...
(Date:11/24/2009)...ent bank KTA Capital,s client Neuren Pharmaceutica...ble note private placement with a U.S. institution... KTA Capital as Neuren,s exclusive placement agent...(PRWEB) November 23, 2009 -- The independent New Y...pital") has announced that its client Neuren ...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...ty, an emerging biotech industry, a well educated ...te. Wisconsin also has a $3.2 billion budget defic...national average. We also rank below the national ...ans we are losing our college graduates to other s... complex problem that cannot be easily solved by a...
...ormation technology software vendor that develops ...are is expanding its solutions to include a module...e records with data from other hospital computer s...a Hartford, Wisconsin developer of systems that al...roll and scheduling challenges. Hospitals require ...
... , , Editors Note: The Wisconsin Technology Netw...thStar Economics 60-page report titled, the North...sin. This report contains a primer for Wisconsin c...ailable in the state. David Ward and his team have...ts on WTN over the next three weeks the third inst...
Other Biology Technology:WARF Collaboration a Win-Win for Wisconsin 2WARF Collaboration a Win-Win for Wisconsin 3API Improves Hospital Efficiency 2Community Development Venture Capital 2Community Development Venture Capital 3Community Development Venture Capital 4Community Development Venture Capital 5Community Development Venture Capital 6
(Date:11/24/2009)...RI) today named 12 new grant recipients for 2009. ...ative work across a broad spectrum of lupus resear...y, and potential to drive scientific discovery to ...sease of systemic lupus. , The 2009 grants go to... the nation and include interdisciplinary and high...
(Date:11/24/2009)...labby arteries from collapsing have been true life... longer needed -- once the arteries are strengthen...ad no choice but to leave them in place. , Prof....ent of Biomedical Engineering has developed a new ...here they,re needed, then dissolves. , "Our new ...
(Date:11/24/2009)...ber 24, 2009) -- The Wildlife Conservation Society... last remaining population of Siberian tigers has ...de of poaching and habitat loss. , W...als of what needs to be done to protect remaining ... The report was released by the Siberian Tig...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2AMN Healthcare Names New Chief Financial Officer 51839 1AMN Healthcare Names New Chief Financial Officer 51839 2AMN Healthcare Names New Chief Financial Officer 51839 3 Colonoscopy Beats Camera Pill at Catching Colon Cancer 51836 1 Colonoscopy Beats Camera Pill at Catching Colon Cancer 51836 2 Colonoscopy Beats Camera Pill at Catching Colon Cancer 51836 3Affordable Health Choices Act Is an Excellent Step Toward Health Care Reform 51832 1Affordable Health Choices Act Is an Excellent Step Toward Health Care Reform 51832 2
...Support MS Expanded Driver,s ... L-1 Identity,Solutions, Inc. (NYSE: ID ), a lead...oday announced that the L-1 Secure Credentialing D...lion contract expansion from the,state of Mississi...river,s,license issuance workstations from L-1 to ...
...n State University have developed a new technology...at could revolutionize the food industry, improvin...g the costly waste and massive recalls of products... are perfectly safe. , The new approach - made po...s in pigment-bearing cells from Siamese fighting f...
...de the fossil conservation of organic tissues, inc...an habitable zone model for recovery after major e... both climate and tectonics; the "celebrated weird...ed carbonate sediments; and a powerful new way to ...robially induced sediment structures to microbial ...
Other Biology News:L-1 Identity Solutions Receives $5.9 Million Driver's License Contract Expansion from the State of Mississippi 2L-1 Identity Solutions Receives $5.9 Million Driver's License Contract Expansion from the State of Mississippi 3Advance offers revolution in food safety testing 2Advance offers revolution in food safety testing 3October 2008 GEOLOGY and GSA TODAY media highlights 2October 2008 GEOLOGY and GSA TODAY media highlights 3October 2008 GEOLOGY and GSA TODAY media highlights 4October 2008 GEOLOGY and GSA TODAY media highlights 5October 2008 GEOLOGY and GSA TODAY media highlights 6October 2008 GEOLOGY and GSA TODAY media highlights 7October 2008 GEOLOGY and GSA TODAY media highlights 8October 2008 GEOLOGY and GSA TODAY media highlights 9October 2008 GEOLOGY and GSA TODAY media highlights 10
...bus is a flexible, fully automated microplate stri...to its fully automated microplate strip washing ca...ith excellent performance and ease of operation. ...de manifolds of 8, 12 or 16 channels, crosswise as...
...Label Transfer Sulfo SBED Protein:Protein Interact...Transfer has rapidly gained traction as an in vitr...ing number of publications feature the exclusive P...agent to study a variety of issues relating to pro...
... Incubator is a compact benchtop and stackable mul...ntroller with a large display screen to accurately...ulation inside to evenly distribute temperature in...ed from the microprocessor controller. Built in ma...
Human siTrio from B-Bridge International
Biology Products: